Cellular Intelligence, a burgeoning biotechnology firm formerly known as Somite AI, has announced a significant strategic acquisition, securing global rights…
Read More
Revolution Medicines’ Daraxonrasib Achieves Landmark Survival Extension in Pancreatic Cancer, Heralding New Era of Targeted Therapy
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer. The 2026…
Read More
Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Dismantling Differentiation Barriers
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
NICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UK
In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…
Read More
A Molecular Switch for Blood Stem Cell Regeneration Could Revolutionize Bone Marrow Transplants and Gene Therapy
In a landmark advancement for regenerative medicine, investigators at Weill Cornell Medicine have identified a specific molecular mechanism that governs…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
A recent population-based study, published in CANCER, a peer-reviewed journal of the American Cancer Society, has brought into sharp focus…
Read More
Researchers Develop Novel Vitamin K Analogues as Potential Regenerative Therapy for Neurodegenerative Diseases
Researchers at the Shibaura Institute of Technology (SIT) in Japan have developed a novel vitamin K analogue that demonstrates significantly…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a rapidly emerging biotech firm previously known as Somite AI, has secured global rights to a pioneering clinical-stage…
Read More
A Groundbreaking Macrophage Therapy Shows Promise for End-Stage Liver Disease Patients
Scientists at the University of Edinburgh have unveiled promising results from the MATCH clinical trial, demonstrating the potential of a…
Read MoreYOU MAY HAVE MISSED
